Chief Scientific Officer of Evotec SE, Dr Cord Dohrmann, will step down effective 30 September.
The decision for Dr Dohrmann to step down from his position was made by mutual consent between Dr Dohrmann and the Company.
Dr Cord Dohrmann, Evotec’s outgoing Chief Scientific Officer, said: ‘The process of advancing new therapies from discovery to the clinic has evolved significantly over the past 16 years, and I have been privileged to contribute to that progress during my time at Evotec. I am grateful for the support and collaboration of the many colleagues I have worked with in that time and look forward to seeing Evotec’s scientific expertise continue to create value for customers, partners and patients.’
Dr Dohrmann has served as Chief Scientific Officer and Member of the management board since 2010. The search for his replacement is ongoing.
